Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anterix Inc. Director's Dealing 2021

Jan 15, 2021

33018_dirs_2021-01-14_a467a0e7-4a79-45c5-a07c-7e683dc0c1fb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2021-01-07

Reporting Person: Ashe Gena L (General Counsel & Secretary)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-01-07 Common Stock A 849 $0.00 Acquired 20555 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-01-07 Stock Option (Right to Buy) $0.00 A 0 Acquired 2031-01-07 Common Stock (0) Direct

Footnotes

F1: Represents the issuance of restricted stock units (the "RSUs"). The RSUs vest in 2 equal annual installments on January 7, 2022 and January 7, 2023.

F2: The stock option previously reported for 849 shares granted on January 7, 2021 was reported in error. The award received by the reporting person was an award for RSUs as now reported on Table I and not a stock option award as previously reported.